nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR5—Peptide GPCRs—CXCR2—periodontitis	0.0282	0.0289	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—CXCR2—periodontitis	0.026	0.0267	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Other—CXCR2—periodontitis	0.0221	0.0226	CbGpPWpGaD
Vapreotide—SSTR5—Peptide GPCRs—CCR2—periodontitis	0.0219	0.0225	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCL3—periodontitis	0.0206	0.0211	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—CXCR2—periodontitis	0.0205	0.021	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—CCR2—periodontitis	0.0202	0.0208	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL3—periodontitis	0.019	0.0195	CbGpPWpGaD
Vapreotide—Octreotide—MPO—periodontitis	0.0188	0.748	CrCbGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL3—periodontitis	0.0174	0.0178	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL3—periodontitis	0.016	0.0164	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—CCR2—periodontitis	0.0159	0.0163	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL3—periodontitis	0.015	0.0153	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0138	0.0142	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCR2—periodontitis	0.0133	0.0136	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0127	0.0131	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL13—periodontitis	0.0127	0.013	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—FCGR2A—periodontitis	0.0127	0.013	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCR2—periodontitis	0.0122	0.0126	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCR2—periodontitis	0.0112	0.0115	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.0111	0.0114	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CCR2—periodontitis	0.011	0.0113	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL3—periodontitis	0.0105	0.0108	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.0104	0.0106	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCR2—periodontitis	0.0103	0.0106	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCR2—periodontitis	0.0103	0.0106	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.01	0.0103	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL13—periodontitis	0.00999	0.0102	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL3—periodontitis	0.0097	0.00995	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCR2—periodontitis	0.00963	0.00988	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00958	0.00983	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCR2—periodontitis	0.00952	0.00976	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00889	0.00912	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.00873	0.00896	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CCR2—periodontitis	0.0087	0.00892	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00821	0.00842	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00807	0.00828	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00804	0.00824	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CCR2—periodontitis	0.00803	0.00824	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1A—periodontitis	0.00799	0.00819	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL10—periodontitis	0.00794	0.00814	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL1A—periodontitis	0.00786	0.00806	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL3—periodontitis	0.00764	0.00783	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL4—periodontitis	0.0076	0.0078	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCR2—periodontitis	0.00749	0.00769	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00745	0.00764	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00742	0.00761	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00692	0.0071	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00689	0.00706	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCR2—periodontitis	0.00677	0.00695	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00646	0.00663	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00638	0.00655	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00636	0.00652	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS2—periodontitis	0.00632	0.252	CrCbGaD
Vapreotide—TACR1—Spinal Cord Injury—TLR4—periodontitis	0.0063	0.00646	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1A—periodontitis	0.00629	0.00645	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL10—periodontitis	0.00625	0.00641	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCR2—periodontitis	0.00625	0.00641	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—NOS2—periodontitis	0.00599	0.00615	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL3—periodontitis	0.00594	0.00609	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL3—periodontitis	0.00548	0.00562	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CCL2—periodontitis	0.0054	0.00554	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL3—periodontitis	0.00539	0.00553	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR2—periodontitis	0.00527	0.0054	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—ADRB1—periodontitis	0.00524	0.00538	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00514	0.00528	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCL2—periodontitis	0.00508	0.00521	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00503	0.00516	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.005	0.00513	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL3—periodontitis	0.00498	0.00511	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCR2—periodontitis	0.00492	0.00505	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR2—periodontitis	0.00486	0.00499	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—ADRB1—periodontitis	0.00484	0.00496	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCL2—periodontitis	0.00469	0.00481	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IFNG—periodontitis	0.0046	0.00471	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—PTGS2—periodontitis	0.00441	0.00452	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00434	0.00445	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL3—periodontitis	0.00432	0.00443	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—VIP—periodontitis	0.00429	0.00441	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CXCL8—periodontitis	0.00427	0.00438	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00416	0.00427	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL1B—periodontitis	0.0041	0.0042	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00402	0.00412	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—VIP—periodontitis	0.00396	0.00407	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL3—periodontitis	0.00392	0.00402	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—VIP—periodontitis	0.0039	0.004	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MMP9—periodontitis	0.00387	0.00396	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCR2—periodontitis	0.00383	0.00393	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR2—periodontitis	0.00383	0.00393	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—ADRB1—periodontitis	0.00381	0.00391	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00371	0.0038	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00369	0.00379	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—VIP—periodontitis	0.0036	0.00369	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCR2—periodontitis	0.00353	0.00362	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCR2—periodontitis	0.00348	0.00357	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00342	0.00351	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00341	0.0035	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL8—periodontitis	0.00339	0.00348	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00328	0.00336	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCR2—periodontitis	0.00321	0.00329	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL3—periodontitis	0.00319	0.00327	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TGFB1—periodontitis	0.00319	0.00327	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00315	0.00323	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL8—periodontitis	0.00313	0.00321	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—VIP—periodontitis	0.00312	0.0032	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—periodontitis	0.00302	0.0031	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR2—periodontitis	0.00298	0.00305	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—periodontitis	0.00297	0.00305	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ADRB1—periodontitis	0.00296	0.00304	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL3—periodontitis	0.00294	0.00302	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00292	0.00299	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—VIP—periodontitis	0.00283	0.00291	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCR2—periodontitis	0.00278	0.00285	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR2—periodontitis	0.00275	0.00282	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ADRB1—periodontitis	0.00274	0.00281	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR2—periodontitis	0.0027	0.00277	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00269	0.00276	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ADRB1—periodontitis	0.00269	0.00276	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL2—periodontitis	0.0026	0.00266	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCR2—periodontitis	0.00253	0.00259	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR2—periodontitis	0.00249	0.00256	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00249	0.00255	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ADRB1—periodontitis	0.00248	0.00255	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00248	0.00254	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—periodontitis	0.00244	0.0025	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—periodontitis	0.0024	0.00246	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL2—periodontitis	0.0024	0.00246	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—periodontitis	0.00238	0.00244	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL3—periodontitis	0.00232	0.00237	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VIP—periodontitis	0.0023	0.00236	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR2—periodontitis	0.00216	0.00222	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ADRB1—periodontitis	0.00215	0.00221	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VIP—periodontitis	0.00213	0.00218	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCR2—periodontitis	0.00205	0.00211	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL8—periodontitis	0.00205	0.0021	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MMP3—periodontitis	0.00205	0.0021	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR2—periodontitis	0.00196	0.00201	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00196	0.00201	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ADRB1—periodontitis	0.00196	0.00201	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—periodontitis	0.00192	0.00197	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCR2—periodontitis	0.00189	0.00194	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL8—periodontitis	0.00189	0.00194	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MMP3—periodontitis	0.00189	0.00194	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL2—periodontitis	0.00189	0.00193	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VIP—periodontitis	0.00167	0.00172	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR2—periodontitis	0.0016	0.00164	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADRB1—periodontitis	0.00159	0.00163	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCR2—periodontitis	0.00149	0.00153	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL8—periodontitis	0.00149	0.00153	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MMP3—periodontitis	0.00149	0.00153	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00149	0.00152	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR2—periodontitis	0.00147	0.00151	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADRB1—periodontitis	0.00147	0.0015	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—periodontitis	0.00133	0.00137	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NTRK1—periodontitis	0.0013	0.00134	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—periodontitis	0.00123	0.00126	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP3—periodontitis	0.00121	0.00124	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NTRK1—periodontitis	0.0012	0.00123	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR2—periodontitis	0.00116	0.00119	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—periodontitis	0.00116	0.00119	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADRB1—periodontitis	0.00116	0.00118	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP3—periodontitis	0.00112	0.00115	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—periodontitis	0.00107	0.0011	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—periodontitis	0.00105	0.00108	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—periodontitis	0.000972	0.000997	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—periodontitis	0.000968	0.000993	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NTRK1—periodontitis	0.000946	0.00097	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP3—periodontitis	0.000879	0.000902	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—periodontitis	0.000843	0.000864	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—periodontitis	0.000787	0.000807	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—periodontitis	0.000765	0.000785	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—periodontitis	0.000726	0.000745	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGF2—periodontitis	0.000711	0.000729	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGF2—periodontitis	0.000656	0.000673	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—periodontitis	0.000622	0.000638	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—periodontitis	0.000592	0.000607	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—periodontitis	0.000574	0.000589	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—periodontitis	0.000572	0.000586	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—periodontitis	0.000563	0.000577	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—periodontitis	0.000546	0.00056	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—periodontitis	0.000519	0.000533	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGF2—periodontitis	0.000517	0.00053	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—periodontitis	0.000464	0.000476	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—periodontitis	0.000452	0.000464	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—periodontitis	0.00043	0.000441	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—periodontitis	0.000428	0.000439	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—periodontitis	0.000409	0.000419	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—periodontitis	0.000349	0.000358	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—periodontitis	0.000337	0.000346	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—periodontitis	0.000323	0.000331	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—periodontitis	0.000254	0.00026	CbGpPWpGaD
